Analyst Price Targets — ALBO
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 11, 2023 4:54 am | — | Cowen & Co. | $48.00 | $43.85 | Benzinga | Cowen & Co. Downgrades Albireo Pharma to Market Perform, Lowers Price Target to $48 |
| January 11, 2023 4:52 am | — | Jefferies | $42.00 | $43.85 | Benzinga | Jefferies Downgrades Albireo Pharma to Hold, Lowers Price Target to $42 |
| January 9, 2023 8:47 am | — | Wedbush | $42.00 | $43.95 | Benzinga | Wedbush Downgrades Albireo Pharma to Neutral, Lowers Price Target to $42 |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
No recent news available for ALBO.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ALBO.
U.S. House Trading
No House trades found for ALBO.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
